Wyeth/Progenics Shoot For Early 2007 Methylnaltrexone NDA Submission

21 Apr 2006

• By The Pink Sheet Daily

Wyeth and partner Progenics plan to a submit an NDA by early 2007 for a new room-temperature formulation of subcutaneous methylnaltrexone for the treatment of opioid-induced side effects

Wyeth/Progenics Shoot For Early 2007 Methylnaltrexone NDA Submission

More from Archive

More from Pink Sheet